The mechanism of HTSJD treatment against obesity with oligoasthenozoospermia by targeting PI3K-AKT and MAPK signaling pathways is demonstrated in Figures 6A,B. Here, AKT1 is linked to obesity due to melanocortin 4 receptor deficiency.